In a groundbreaking effort to reduce cervical cancer cases, women over the age of 25 in England who frequently miss cervical screening appointments will soon be offered the option to perform self-administered human papillomavirus (HPV) tests at home.
HPV is the primary cause of the majority of cervical cancer cases, and early detection is crucial for effective treatment. Following endorsement from the UK National Screening Committee in March, the NHS plans to launch this self-sampling initiative starting January next year.
Currently, the NHS invites women aged 25 to 64 for cervical screenings every three years. However, many women skip these appointments due to time constraints, discomfort, or embarrassment. Recent NHS statistics indicate that five million women are overdue for cervical screening.
READ MORE: Check Birthday Cards for This ‘Lesser-Known’ Sign of Dementia
READ MORE: Greater Gloucester council bid driven by leader’s decades-long ambition amid council abolition threat
To tackle this issue, the NHS will send self-sampling kits through the post to women who have rarely or never attended their routine screenings. The kits can be used at home and returned via prepaid mail. Women who test positive for HPV will be advised to schedule follow-up appointments with healthcare providers for further assessment.
Research demonstrates that this approach could significantly improve screening participation. The YouScreen trial, led by King’s College London in partnership with NHS England, found that self-sampling kits increased screening uptake among under-screened women by approximately 400,000 annually. The Department of Health and Social Care estimates that this initiative could save around 5,000 lives each year in England by detecting cervical cancer earlier.
The program focuses on including groups traditionally less likely to attend screenings, such as younger women, ethnic minorities, individuals with disabilities, and those within the LGBT+ community.
Health and Social Care Secretary Wes Streeting said, “These self-sampling kits give women control over their health and help us detect more cancers at their earliest, most treatable stages. Making screening more accessible is key to overcoming barriers that prevent millions of women from accessing life-saving tests.”
Dr Anita Lim, chief investigator of the YouScreen trial, added, “This is a major advancement in cervical cancer prevention and gets us closer to eliminating this disease by 2040. Self-sampling reaches people who struggle to attend traditional screenings, extending protection to diverse and underserved populations.”
Michelle Kane, NHS England’s director of screening, encouraged women to take advantage of the new option, saying, “We hope self-testing will encourage more women to participate in this life-saving screening at their convenience. If you receive an invitation for cervical screening or experience any concerning symptoms, please contact your GP as soon as possible—it could save your life.”